INCR
InterCure Ltd.
5.50$
+0.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q1 25 | Q2 25 | Q3 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 40.9% | -49.5% | 0.9% | – | – | -34.6% | -34.6% | – | 9.4% | 9.4% | 3.3% | 24.0% | 11.6% | |
| 4.1% | 3.0% | 0.9% | – | – | 5.0% | 5.0% | – | 6.5% | 6.5% | 6.2% | 6.2% | 6.3% | |
| 2.6% | 1.3% | 0.9% | 0.2% | – | 0.5% | 0.5% | 1.4% | 0.7% | 0.7% | 1.1% | 1.1% | 0.9% | |
| 3.4% | 3.4% | – | – | – | – | – | – | – | – | – | – | – | |
| 49.2% | -56.0% | 0.3% | – | – | -36.2% | -36.2% | – | -11.5% | -11.5% | 30.4% | 30.4% | 10.2% | |
| 4.4% | 0.6% | 0.0% | 0.0% | – | 0.3% | 0.3% | 0.0% | 2.5% | 2.5% | 0.2% | 5.1% | 2.6% | |
| -13.7% | -13.6% | – | – | – | 8.8% | 8.8% | – | -3.3% | -3.3% | 1.7% | -2.8% | -1.9% | |
| 0.0% | 0.0% | – | – | – | – | – | – | – | – | – | – | – | |
| -52.3% | -52.0% | – | – | – | – | – | – | – | – | – | – | – | |
| 35.2% | -55.9% | – | – | – | -38.8% | -38.8% | – | -26.8% | -26.8% | -8.4% | -66.6% | -32.4% | |
| 16.7% | -118.9% | 0.9% | – | – | – | – | – | – | – | – | -45.4% | – | |
| 36.4% | -50.1% | 0.9% | – | – | -34.9% | -34.9% | – | 6.9% | 6.9% | 3.1% | 19.0% | 9.0% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.